Singular Health Group (SHG) Fundamentals 2026 — Revenue Analysis | SniperIQ
Singular Health Group (SHG) is a AU-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of A$65M, trading at A$0.20 on the ASX. This SniperIQ fundamentals page covers Singular Health Group's valuation, profitability (net margin -772.8%), revenue (A$557,608 in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Singular Health Group's market cap?
Singular Health Group (SHG) has a market capitalization of approximately A$65M, trading at A$0.20 on the ASX. Market cap moves with the live share price.
What is Singular Health Group's P/E ratio?
Singular Health Group's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 5.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Singular Health Group?
Singular Health Group runs a net profit margin of -772.8%, a gross margin of -208.8%, and an operating margin of -809.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Singular Health Group generate?
Singular Health Group reported revenue of A$557,608 for fiscal year 2025, with net income of -A$6M and earnings per share (EPS) of -0.0264. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Singular Health Group pay a dividend?
Singular Health Group does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Singular Health Group financially healthy?
Singular Health Group carries a debt-to-equity ratio of 0.01x and a current ratio of 15.98x, with a market beta of -0.03. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Singular Health Group a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Singular Health Group (SHG) the key facts are: market cap A$65M, revenue A$557,608, 52-week range 0.17-0.36. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Singular Health Group's full fundamentals live
Get Singular Health Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.